By Josh White
Date: Wednesday 05 Jan 2022
(Sharecast News) - Organ transplant clinical diagnosis developer Verici Dx announced a collaboration with Nasdaq-listed Illumina on Wednesday, to expedite the operational launch of data analysis processing and the predictive artificial intelligence component of its products using early access to Illumina's new software platform ICA.
By Abigail Townsend
Date: Monday 21 Sep 2020
(Sharecast News) - US healthcare firm Illumina is to take full control of blood test specialist Grail in a $8bn cash and stock deal, it was announced on Monday.
No recent information was found.
Currency | US Dollars |
Share Price | $ 136.99 |
Change Today | $ 5.31 |
% Change | 4.03 % |
52 Week High | $155.15 |
52 Week Low | $94.65 |
Volume | 2,026,178 |
Shares Issued | 159.00m |
Market Cap | $21,781m |
RiskGrade | 221 |
Strong Buy | 6 |
Buy | 4 |
Neutral | 11 |
Sell | 2 |
Strong Sell | 0 |
Total | 23 |
Time | Volume / Share Price |
15:59 | 100 @ $137.09 |
15:59 | 100 @ $137.06 |
15:59 | 100 @ $137.06 |
15:59 | 100 @ $137.07 |
15:59 | 100 @ $137.07 |
You are here: research